Vertessen, Karen
Oosterlaan, Jaap
Bet, Pierre
Bottelier, Marco
Stoffelsen, Reino
Swanson, James M.
Wisse, Annemiek
Twisk, Jos
Luman, Marjolein
Funding for this research was provided by:
Innovatiefonds Zorgverzekeraars (p3119, p3119, p3119, p3119)
Article History
Received: 5 December 2023
Accepted: 30 July 2024
First Online: 10 August 2024
Declarations
:
: Karen Vertessen has been involved in a clinical trial sponsored by Takeda. The other authors have no conflict of interest relevant to this article to disclose.